Potential risk factors for diabetic neuropathy: a case control study

[1] Larijani B(2002)Epidemiology of diabetes mellitus in Iran Iranian Journal of Diabetes and Lipid Disorders 1 1-8

[2] Zahedi F(1993)The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study Neurology 43 817-824

[3] Dyck PJ(1999)New insights into the pathogenesis of diabetic neuropathy Curr Opin Neurol 12 553-563

[4] Kratz KM(1998)The role of axonal ion conductances in diabetic neuropathy: a review Muscle Nerve 21 1246-1255

[5] Karnes JL(1998)Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved Biofactors 8 41-43

[6] Litchy WJ(1998)Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in treptozotocin-induced diabetic rats Metabolism 47 977-981

[7] Klein R(1998)Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids Diabetologia 41 390-399

[8] Pach JM(1994)A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy Diabetes Care 17 1281-1289

[9] Wilson DM(1998)A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy Diabetes Res Clin Pract 39 165-172

[10] O'Brien PC(1996)Prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors. The Euro Diab IDDM complications study Diabetologia 39 1377-1384

[1] Larijani B(2002)Epidemiology of diabetes mellitus in Iran Iranian Journal of Diabetes and Lipid Disorders 1 1-8

[2] Zahedi F(1993)The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study Neurology 43 817-824

[3] Dyck PJ(1999)New insights into the pathogenesis of diabetic neuropathy Curr Opin Neurol 12 553-563

[4] Kratz KM(1998)The role of axonal ion conductances in diabetic neuropathy: a review Muscle Nerve 21 1246-1255

[5] Karnes JL(1998)Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved Biofactors 8 41-43

[6] Litchy WJ(1998)Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in treptozotocin-induced diabetic rats Metabolism 47 977-981

[7] Klein R(1998)Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids Diabetologia 41 390-399

[8] Pach JM(1994)A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy Diabetes Care 17 1281-1289

[9] Wilson DM(1998)A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy Diabetes Res Clin Pract 39 165-172

[10] O'Brien PC(1996)Prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors. The Euro Diab IDDM complications study Diabetologia 39 1377-1384